In this review, we will focus on the role of CUG repeats in the misregulation of the GSK3β-CUGBP1 pathway in DM1 pathogenesis and discuss recent findings, which describe how correction of this pathway may reduce DM1 and CDM1 pathology. Here, CELF1 is linked to myotonic dystrophy type 1.